Target Versus Below-Target Dose ACE Inhibitors in U.S. Veterans with HFpEF: Differential Outcomes by CKD Status

By afschroeder • July 31, 2026

Lu F, Ahmed AA, Zhang S, Raman VK, Patel SS, Vargas JD, Fonarow GC, Heidenreich PA, Cleland JGF, Anker SD, Böhm M, Metra M, Zile MR, Bhatt DL, Ahmad T, Lam PH, Moore HJ, Faselis C, Morgan CJ, Sheriff HM, Zeng-Treitler Q, Wu WC, Ahmed A. Target Versus Below-Target Dose ACE Inhibitors in U.S. Veterans with HFpEF: Differential Outcomes by CKD Status. Eur J Heart Fail. 2026 Jul 30:xuag237. doi: 10.1093/ejhf/xuag237. Epub ahead of print. PMID: 42530463.

Tags: Cardiology/Epi, Publications

Related Posts

Timeliness of Emergency Care for Intracerebral Hemorrhage Compared With Acute Ischemic Stroke

Royan R, Ikeaba U, Alhanti B, Stamm B, Mac Grory B, Prabhakaran S, Maas MB, Fonarow GC, Messe SR, Mamer LE, Goldstein JN, Saver JL,[...]

Genetically engineering mast cells as effectors for targeted cancer cell cytotoxicity

Han X, Wen D, Fu R, Soto J, Song Y, Wu Y, Wang Z, Lin X, Yu J, Sheng T, Li S, Gu Z, He[...]

Design of Screening Cardiometabolic Opportunities Using Transformative Echocardiography Artificial Intelligence (SCOUT-Echo-AI)

Eusuff S, Kim J, Fatima Z, Yalcinkaya D, Sahashi Y, Sandhu A, Nguyen LH, Ambrosy AP, Cheng PP, Chang ST, Go AS, Ahmad FS, Cheung[...]